President Trump wants the Food and Drug Administration to approve drugs faster, but researchers at the Yale School of Medicine found that nearly a third of medications that reached the market from 2001 through 2010 had major safety issues years after they became widely available to patients.

Seventy-one of these 222 drugs were withdrawn, required a “black box” warning about serious side effects, or warranted a safety announcement about new risks to the public, Yale professor Dr. Joseph Ross and his colleagues reported in JAMA on Tuesday. The study included safety actions through Feb. 28.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • You are trying to change a single chemical reaction inside a person where over a billion unique reactions occur. I’m surprised only 1/3 of new drugs have safety concerns. At the end of the day you can’t determine the longterm effects of drugs or even see rarer side effects with small control groups. Drugs should be approved faster and better records should be kept to spot these problems early.
    New drugs are a shot in the dark, years of FDA study doesn’t increase safety, it merely slows down progress.

  • Wow! To say the least? I take many ssri’s and an atypical anticycotic. For depression anxiety and OCD. Now im going to do more reaserch but this is very unsettling. I dont want to die early because of a med. But I still know the benifbenefits these drugs have given me. A big dilemma. It seems like alot of government agency’s are not doing a good job these days? I just wish that they could have cot these negative side effects sooner before releasing then to the public. There’s already enough negative side effects to begin with. Now you have more side effects to look forword to. Thanks FDA?!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy